139 related articles for article (PubMed ID: 25917075)
21. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC
Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
[TBL] [Abstract][Full Text] [Related]
22. The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways.
Labalette C; Nouët Y; Levillayer F; Armengol C; Renard CA; Soubigou G; Xia T; Buendia MA; Wei Y
PLoS One; 2008; 3(11):e3761. PubMed ID: 19018287
[TBL] [Abstract][Full Text] [Related]
23. Translocation of a human focal adhesion LIM-only protein, FHL2, during myofibrillogenesis and identification of LIM2 as the principal determinants of FHL2 focal adhesion localization.
Li HY; Kotaka M; Kostin S; Lee SM; Kok LD; Chan KK; Tsui SK; Schaper J; Zimmermann R; Lee CY; Fung KP; Waye MM
Cell Motil Cytoskeleton; 2001 Jan; 48(1):11-23. PubMed ID: 11124707
[TBL] [Abstract][Full Text] [Related]
24. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
Li M; Wang J; Ng SS; Chan CY; Chen AC; Xia HP; Yew DT; Wong BC; Chen Z; Kung HF; Lin MC
Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
[TBL] [Abstract][Full Text] [Related]
25. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
Kleiber K; Strebhardt K; Martin BT
Anticancer Res; 2007; 27(1A):55-61. PubMed ID: 17352216
[TBL] [Abstract][Full Text] [Related]
26. β8 Integrin Mediates Pancreatic Cancer Cell Radiochemoresistance.
Jin S; Lee WC; Aust D; Pilarsky C; Cordes N
Mol Cancer Res; 2019 Oct; 17(10):2126-2138. PubMed ID: 31337672
[TBL] [Abstract][Full Text] [Related]
27. FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29.
Amann T; Egle Y; Bosserhoff AK; Hellerbrand C
Oncol Rep; 2010 Jun; 23(6):1669-74. PubMed ID: 20428824
[TBL] [Abstract][Full Text] [Related]
28. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
29. The roles of FHL2 in cancer.
Zhang J; Zeng Q; She M
Clin Exp Med; 2023 Nov; 23(7):3113-3124. PubMed ID: 37103649
[TBL] [Abstract][Full Text] [Related]
30. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
31. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
32. Deletion of the FHL2 gene attenuates intima-media thickening in a partially ligated carotid artery ligated mouse model.
Chen CY; Tsai HY; Tsai SH; Chu PH; Huang PH; Chen JW; Lin SJ
J Cell Mol Med; 2020 Jan; 24(1):160-173. PubMed ID: 31714683
[TBL] [Abstract][Full Text] [Related]
33. The FHL2 regulation in the transcriptional circuitry of human cancers.
Cao CY; Mok SW; Cheng VW; Tsui SK
Gene; 2015 Nov; 572(1):1-7. PubMed ID: 26211626
[TBL] [Abstract][Full Text] [Related]
34. SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma.
Rauth S; Karmakar S; Shah A; Seshacharyulu P; Nimmakayala RK; Ganguly K; Bhatia R; Muniyan S; Kumar S; Dutta S; Lin C; Datta K; Batra SK; Ponnusamy MP
Mol Cell Biol; 2021 Nov; 41(12):e0013521. PubMed ID: 34570619
[TBL] [Abstract][Full Text] [Related]
35. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes.
Purcell NH; Darwis D; Bueno OF; Müller JM; Schüle R; Molkentin JD
Mol Cell Biol; 2004 Feb; 24(3):1081-95. PubMed ID: 14729955
[TBL] [Abstract][Full Text] [Related]
36. FHL2 interacts with iASPP and impacts the biological functions of leukemia cells.
Lu W; Yu T; Liu S; Li S; Li S; Liu J; Xu Y; Xing H; Tian Z; Tang K; Rao Q; Wang J; Wang M
Oncotarget; 2017 Jun; 8(25):40885-40895. PubMed ID: 28402264
[TBL] [Abstract][Full Text] [Related]
37. Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells.
Jin H; Lee K; Kim YH; Oh HK; Maeng YI; Kim TH; Suh DS; Bae J
Oncogene; 2016 Sep; 35(39):5106-18. PubMed ID: 26973248
[TBL] [Abstract][Full Text] [Related]
38. α integrin targeting for radiosensitization of three-dimensionally grown human head and neck squamous cell carcinoma cells.
Steglich A; Vehlow A; Eke I; Cordes N
Cancer Lett; 2015 Feb; 357(2):542-8. PubMed ID: 25497870
[TBL] [Abstract][Full Text] [Related]
39. Expression and purification of GST-FHL2 fusion protein.
Yu H; Ma Q; Lin J; Sun YF; Zheng F
Genet Mol Res; 2013 Dec; 12(4):6372-8. PubMed ID: 24390986
[TBL] [Abstract][Full Text] [Related]
40. The CDK inhibitor p57
Kullmann MK; Podmirseg SR; Roilo M; Hengst L
Sci Rep; 2020 Apr; 10(1):7140. PubMed ID: 32346031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
